SAMA’s Announcement Provides Saudi Banks Right to Reduce Customers’ Service Fees

SAMA’s Announcement Provides Saudi Banks Right to Reduce Customers’ Service Fees
TT

SAMA’s Announcement Provides Saudi Banks Right to Reduce Customers’ Service Fees

SAMA’s Announcement Provides Saudi Banks Right to Reduce Customers’ Service Fees

Saudi banks have revealed that Saudi Arabian Monetary Agency’s (SAMA) announcement on the maximum limit of fees for banking services does not bind banks to exercise their right to reduce fees for services provided to their customers.

Instead, banks are obliged not to charge more than the maximum limit for the fees of the services concerned.

Secretary-General of the Media and Banking Awareness Committee for Saudi Banks Talat Hafez told Asharq al-Awsat that SAMA has set service fees at the retail sector level, but it didn’t set the maximum limit in terms of financing.

He said loans are determined by many factors, including those related to the market, the cost of money at banks, and several other elements.

As for public services, most of which are provided to individuals, Hafez said SAMA has set binding limits for all banks, such as revealing the cost of an account statement or the cost of issuing an ATM card.

“SAMA has asked banks not to exceed the specified fee limit for any of their services,” he explained.

However, the Saudi banks' spokesman added, it has given Saudi banks the right to reduce these fees by receiving less than the fees specified in any of the services concerned according to the nature and evaluation of the relationship between the bank and the customer.

One of the instructions SAMA has issued is for Saudi banks to provide a statement of these fees in a prominent place in the banking branch in order to enhance transparency so that any customer can access them easily and without restrictions.

Hafez said SAMA’s step comes in line with regulating the relationship between banks and their customers and providing full transparency that fosters trust for beneficiaries.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.